“GSK Expands Respiratory Portfolio with Aiolos Bio Acquisition”
GSK's acquisition of Aiolos Bio expands respiratory treatment options, introducing AIO-001, a promising new treatment for asthma patients.
- Latest
- Trending
GSK's acquisition of Aiolos Bio expands respiratory treatment options, introducing AIO-001, a promising new treatment for asthma patients.
A smartphone app using AI to analyze cough sounds shows promise in diagnosing TB, offering a valuable screening tool in ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.